Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONTX

Onconova Therapeutics (ONTX) Stock Price, News & Analysis

Onconova Therapeutics logo

About Onconova Therapeutics Stock (NASDAQ:ONTX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.67
$1.01
52-Week Range
N/A
Volume
1.28 million shs
Average Volume
96,681 shs
Market Capitalization
$20.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Onconova Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ONTX Stock News Headlines

TRAW Traws Pharma, Inc.
Onconova and Trawsfynydd merge to form Traws Pharma
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Onconova Acquires Trawsfynydd To Form Traws Pharma
Traws Pharma Announces New Employee Inducement Grants
See More Headlines

ONTX Stock Analysis - Frequently Asked Questions

Onconova Therapeutics, Inc. (NASDAQ:ONTX) released its quarterly earnings results on Thursday, November, 11th. The biopharmaceutical company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.33) by $0.11. The biopharmaceutical company had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.06 million. Onconova Therapeutics had a negative trailing twelve-month return on equity of 95.43% and a negative net margin of 8,930.97%.

Shares of Onconova Therapeutics reverse split before market open on Friday, May 21st 2021.The 1-15 reverse split was announced on Thursday, May 20th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 20th 2021. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Onconova Therapeutics investors own include Tonix Pharmaceuticals (TNXP), Ocugen (OCGN), Bionano Genomics (BNGO), NIO (NIO), OPKO Health (OPK), Sorrento Therapeutics (SRNE) and FuelCell Energy (FCEL).

Company Calendar

Last Earnings
11/11/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ONTX
CIK
1130598
Employees
16
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.96 million
Net Margins
-8,930.97%
Pretax Margin
-8,930.97%
Return on Equity
-95.43%
Return on Assets
-61.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.79
Quick Ratio
2.79

Sales & Book Value

Annual Sales
$230 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
21,000,000
Free Float
20,310,000
Market Cap
$20.90 million
Optionable
Optionable
Beta
1.38

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ONTX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners